
Andere Körperregionen
Weitere Probleme bei Mukoviszidose
Da das
*CFTR = Cystic Fibrosis Transmembrane Conductance Regulator
Referenzen
-
Welsh MJ et al., „Cystic fibrosis: membrane transport disorders“, in Valle D, Beaudet A, Vogelstein B et al. eds. The Online Metabolic & Molecular Bases of Inherited Disease, The McGraw-Hill Companies Inc, www.ommbid.com,2004, part 21, chap 201.
-
Rowe S et al., „Mechanisms of Disease: Cystic Fibrosis,“ The New England Journal of Medicine, Bd. 352, pp. 1992-2001, 2005.
-
National Heart, Lung and Blood Institute, „The Respiratory System“, [Online]. Available: http://www.nhlbi.nih.gov/health/health-topics/topics/hlw/system. [Zugriff am 06 Oktober 2016].
-
Derichs N, „Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis“, European Respiratory Review, 22, 127, 58-65, 2013.
-
National Heart Lung and Blood Institute, „What is Cystic Fibrosis?“, [Online]. Verfügbar unter: http://www.nhlbi.nih.gov/health/health-topics/topics/cf. [Zugriff am 12 Oktober 2016].
-
Cystic Fibrosis Foundation, „About Cystic Fibrosis“, [Online]. Verfügbar unter: https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/. [Zugriff am 06 Oktober 2016].
-
O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373 (9678): 1891–1904.
-
de Boer K et al., „Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis“, Thorax, 680-685, 2011.
-
Smyth AR, Bell SC, Bojcin S et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014;13 Suppl 1:S23-42.
-
Cystic Fibrosis Foundation, „The digestive tract“, [Online]. Verfügbar unter: https://www.cff.org/Living-with-CF/Treatments-and-Therapies/Nutrition/The-Digestive-Tract/. [Zugriff am 06 Oktober 2016].
-
John Hopkins CF Centre, „Diabetes“, [Online]. Verfügbar unter: http://www.hopkinscf.org/living-with-cf/managing-treatments/diabetes/. [Zugriff am 06 Oktober 2016].
-
Colombo C et al., „Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients“, Journal of Cystic Fibrosis , 10, 2, 24-28, 2011.
-
John Hopkins CF Centre, „Intestinal Problems“, [Online]. Verfügbar unter: http://www.hopkinscf.org/what-is-cf/effects-of-cf/pancreas-gastrointestinal-tract/intestinal-problems/. [Zugriff am 12 Oktober 2016].
-
Robinson N, DiMango E, „Prevalence of Gastroesophageal Reflux in Cystic Fibrosis and Implications for Lung Disease“, Annals of the American Thoracic Society, 6, 964-968, 2014.
-
Kelly T, Buxbaum J, „Gastrointestinal Manifestation of Cystic Fibrosis“, Digestive Diseases and Sciences, 60, 7, 1903-1913, 2015.
-
Cystic Fibrosis Trust, „Additional Complications“, [Online]. Verfügbar unter: https://www.cysticfibrosis.org.uk/what-is-cystic-fibrosis/how-cf-affects-the-body/complications. [Zugriff am 20 Oktober 2016].
-
Wenk K et al., „Cystic Fibrosis Presenting With Dermatitis“, Archives of Dermatology, 146, 2, 171-174, 2010.
-
Faller A, „Verdauungssystem - Leber“, in Der Körper des Menschen, Stuttgart/New York, Georg Thieme Verlag, 1995, 293-296.
-
Kinder- und Jugendärzte im Netz, „Mukoviszidose (Cystische Fibrose) - Auswirkungen“, 28. März 2016. [Online]. Verfügbar unter: http://www.kinderaerzte-im-netz.de/krankheiten/mukoviszidose-cystische-fibrose/auswirkungen/. [Zugriff am 17 Oktober 2016].
-
Dodge JA, „Male fertility in cystic fibrosis“, The Lancet, 587-588, 1995.
-
Davis P, „Cystic Fibrosis Since 1938“, American Journal of Respiratory and Critical Care Medicine, 475-482, 2006.
-
Cystic Fibrosis Trust, „Thinking of starting a family? (Fertility pack)“, [Online]. Verfügbar unter: https://www.cysticfibrosis.org.uk/news/a-fertile-source-of-information. [Zugriff am 20 Oktober 2016].
-
King SJ et al., „Reduced bone density in cystic fibrosis: DF508 mutation is an independent risk factor“, European Respiratory Journal, 25, 54-61, 2005.
-
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, „AWMF-Leitlinie: Mukoviszidose (cystische Fibrose): Ernährung und exokrine Pakreasinsuffizienz“, 2011.